Pseudomonas aeruginosa DNA-fingerprinting of colonized CF-patients in a rehabilitation centre: a 2-years surveySource: Eur Respir J 2003; 22: Suppl. 45, 174s Year: 2003
Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients Source: Eur Respir J 2006 Oct 01;28(4):740-747 Year: 2006
The clinical impact of Pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral centre Source: Eur Respir J, 53 (4) 1802081; 10.1183/13993003.02081-2018 Year: 2019
Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005
Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017
Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty? Source: Eur Respir J 2010; 35: 473-474 Year: 2010
Does a single Pseudomonas aeruginosa isolation predict COPD mortality? Source: Eur Respir J 2014; 44: 794-797 Year: 2014
Dental units as infection sources of Pseudomonas aeruginosa Source: Eur Respir J 2008; 32: 1122-1123 Year: 2008
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients Source: Eur Respir J, 52 (2) 1701190; 10.1183/13993003.01190-2017 Year: 2018
Newly acquired pseudomonas aeruginosa in Belgian cystic fibrosis-patients: does the patients‘ P. aeruginosa genotype correlate with environmental genotypes? Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006
DNA fingerprinting of Pseudomonas aeruginosa (Pa) in cystic fibrosis patients: risk assessment of cross-colonisation in a CF revalidation centre Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002
Late Breaking Abstract - The prevalence and burden of Pseudomonas aeruginosa among bronchiectasis patients in Europe- data from the FRIENDS cohort Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections Year: 2017
Newly acquired pseudomonas aeruginosa (P.a.) in Belgian CF-patients: does the patients‘ P.a. genotype correlate with environmental genotypes? Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems Year: 2004
Klebsiella pneumoniae respiratory isolates in an urban-based general hospital - trends and characteristics between 1998 and 2003Source: Eur Respir J 2005; 26: Suppl. 49, 258s Year: 2005
PES (Pseudomonas , Enterobacteriaceae S. Aureus MR) a new clinical acronym to identify MDR pneumonias in the community Source: International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia Year: 2014
Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa Source: Eur Respir J 2011; 38: 409-414 Year: 2011
Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020
Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?> Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep? Year: 2017
Antibiotic susceptibility patterns of respiratory strains of Staphylococcus aureus in a Turkish university hospital Source: Eur Respir J 2003; 22: Suppl. 45, 148s Year: 2003
Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres Source: Eur Respir J 2013; 41: 1091-1100 Year: 2013